In the BioHarmony Drug Report Database

"Preview" Icon

Imipenem

Primaxin, Recarbrio (imipenem) is a small molecule pharmaceutical. Imipenem was first approved as Primaxin on 1985-11-26. It is used to treat bacterial endocarditis, bacterial infections, enterobacteriaceae infections, infectious bone diseases, and intraabdominal infections amongst others in the USA. It has been approved in Europe to treat gram-negative bacterial infections.

 

Trade Name

 

Recarbrio
 

Common Name

 

imipenem
 

ChEMBL ID

 

CHEMBL148
 

Indication

 

bacterial endocarditis, bacterial infections, enterobacteriaceae infections, gram-negative bacterial infections, infectious bone diseases, intraabdominal infections, pelvic infection, pseudomonas infections, respiratory tract infections, staphylococcal infections, streptococcal infections, urinary tract infections
 

Drug Class

 

Antibacterial antibiotics, carbapenem derivatives

Image (chem structure or protein)

Imipenem structure rendering